| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA4135584 | B | Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay | Homo sapiens | 36 | single protein format | Scientific Literature | ||
| 2. | ALA4135587 | A | Extraction ratio in human liver microsomes at 1 uM up to 30 mins in presence of NADPH by LC-MS/MS analysis | Homo sapiens | 22 | microsome format | Scientific Literature | ||
| 3. | ALA4135588 | A | Extraction ratio in mouse liver microsomes at 1 uM up to 30 mins in presence of NADPH by LC-MS/MS analysis | Mus musculus | 22 | microsome format | Scientific Literature | ||
| 4. | ALA4135589 | A | Extraction ratio in rat liver microsomes at 1 uM up to 30 mins in presence of NADPH by LC-MS/MS analysis | Rattus norvegicus | 10 | microsome format | Scientific Literature | ||
| 5. | ALA4135593 | A | Clearance in CD-1 mouse at 2 mg/kg, iv or 10 mg/kg, po | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 6. | ALA4135594 | A | Volume of distribution at steady state in CD-1 mouse at 2 mg/kg, iv or 10 mg/kg, po | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 7. | ALA4135595 | A | Half life in CD-1 mouse at 2 mg/kg, iv or 10 mg/kg, po | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 8. | ALA4135596 | A | AUC in CD-1 mouse at 2 mg/kg, iv | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 9. | ALA4135597 | A | AUC in CD-1 mouse at 10 mg/kg, po | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 10. | ALA4135598 | A | Cmax in CD-1 mouse at 10 mg/kg, po | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 11. | ALA4135599 | A | Oral bioavailability in CD-1 mouse at 10 mg/kg | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 12. | ALA4135600 | A | Clearance in Wistar rat at 5 mg/kg, iv or 20 mg/kg, po | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
| 13. | ALA4135601 | A | Volume of distribution at steady state in Wistar rat at 5 mg/kg, iv or 20 mg/kg, po | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
| 14. | ALA4135602 | A | Half life in Wistar rat at 5 mg/kg, iv or 20 mg/kg, po | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
| 15. | ALA4135603 | A | AUC in Wistar rat at 5 mg/kg, iv | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
| 16. | ALA4135604 | A | AUC in Wistar rat at 20 mg/kg, po | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
| 17. | ALA4135605 | A | Cmax in Wistar rat at 20 mg/kg, po | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
| 18. | ALA4135606 | A | Oral bioavailability in Wistar rat at 20 mg/kg | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
| 19. | ALA4135607 | A | Clearance in Beagle dog at 0.5 mg/kg, iv or 2 mg/kg, po | Canis lupus familiaris | 1 | organism-based format | Scientific Literature | ||
| 20. | ALA4135608 | A | Volume of distribution at steady state in Beagle dog at 0.5 mg/kg, iv or 2 mg/kg, po | Canis lupus familiaris | 1 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!